![Nicholas Maestas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Maestas
Finanzdirektor/CFO bei
RANI THERAPEUTICS HOLDINGS, INC.
Vermögen: 903 $ am 31.05.2026
Profil
Nicholas Maestas is currently Chief Financial & Accounting Officer at Rani Therapeutics Holdings, Inc. since 2026.
Formerly, Mr. Maestas was Chief Financial Officer, Secretary & Head-Strategy at Tempest Therapeutics, Inc. from 2025 to 2026, Head-Financial Planning & Analysis at Alector, Inc. from 2019 to 2021, and Senior Director-Corporate Development & Operations at Immune Design Corp.
in 2019.
Mr. Maestas completed undergraduate education at the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 590 ( 0 % ) | 903 $ | 31.05.2026 |
Aktive Positionen von Nicholas Maestas
| Unternehmen | Position | Beginn |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Finanzdirektor/CFO | 29.06.2026 |
Ehemalige bekannte Positionen von Nicholas Maestas
| Unternehmen | Position | Ende |
|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Finanzdirektor/CFO | 05.06.2026 |
| ALECTOR, INC. | Corporate Officer/Principal | 01.07.2021 |
| IMMUNE DESIGN CORP | Corporate Officer/Principal | 01.07.2019 |
Ausbildung von Nicholas Maestas
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
22
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tempest Therapeutics, Inc.
 Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
Rani Therapeutics Holdings, Inc.
 Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
Wählen Sie MarketScreener 
